Literature DB >> 10554015

Frequent loss of imprinting of PEG1/MEST in invasive breast cancer.

I S Pedersen1, P A Dervan, D Broderick, M Harrison, N Miller, E Delany, D O'Shea, P Costello, A McGoldrick, G Keating, B Tobin, T Gorey, A McCann.   

Abstract

The human PEG1 gene is a newly identified imprinted gene on 7q32. Genetic aberrations of this chromosomal region are often detected in invasive breast carcinomas. In this study, we show monoallelic PEG1 expression in normal breast tissue, indicating the presence of a functional imprint, and more importantly, we demonstrate loss of imprinting (LOI) in all of seven informative invasive breast carcinomas. In contrast to this, in one case of atypical ductal hyperplasia (ADH) found in residual breast, imprinting was maintained. This raises the possibility that aberrant imprinting of PEG1 may be involved in the progression from hyperplasia to invasive breast cancer.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10554015

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  29 in total

1.  Aberrant methylation of imprinted genes is associated with negative hormone receptor status in invasive breast cancer.

Authors:  Timothy M Barrow; Ludovic Barault; Rachel E Ellsworth; Holly R Harris; Alexandra M Binder; Allyson L Valente; Craig D Shriver; Karin B Michels
Journal:  Int J Cancer       Date:  2015-01-21       Impact factor: 7.396

Review 2.  Post-natal imprinting: evidence from marsupials.

Authors:  J M Stringer; A J Pask; G Shaw; M B Renfree
Journal:  Heredity (Edinb)       Date:  2014-03-05       Impact factor: 3.821

3.  Long intergenic noncoding RNA LINC00284 knockdown reduces angiogenesis in ovarian cancer cells via up-regulation of MEST through NF-κB1.

Authors:  Zhengyi Ruan; Dong Zhao
Journal:  FASEB J       Date:  2019-10-01       Impact factor: 5.191

Review 4.  The origin and evolution of genomic imprinting and viviparity in mammals.

Authors:  Marilyn B Renfree; Shunsuke Suzuki; Tomoko Kaneko-Ishino
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-01-05       Impact factor: 6.237

5.  In vitro lead exposure changes DNA methylation and expression of IGF2 and PEG1/MEST.

Authors:  Monica D Nye; Cathrine Hoyo; Susan K Murphy
Journal:  Toxicol In Vitro       Date:  2015-01-14       Impact factor: 3.500

6.  Variable imprinting of the MEST gene in human preimplantation embryos.

Authors:  John D Huntriss; Karen E Hemmings; Matthew Hinkins; Anthony J Rutherford; Roger G Sturmey; Kay Elder; Helen M Picton
Journal:  Eur J Hum Genet       Date:  2012-07-04       Impact factor: 4.246

7.  The novel imprinted carboxypeptidase A4 gene ( CPA4) in the 7q32 imprinting domain.

Authors:  Tomohiko Kayashima; Kentaro Yamasaki; Takahiro Yamada; Hideki Sakai; Nobutomo Miwa; Tohru Ohta; Koh-ichiro Yoshiura; Naomichi Matsumoto; Yoshibumi Nakane; Hiroshi Kanetake; Fumitoshi Ishino; Norio Niikawa; Tatsuya Kishino
Journal:  Hum Genet       Date:  2003-01-28       Impact factor: 4.132

8.  Differential gene expression profiling in human cholangiocarcinoma cells treated with Clonorchis sinensis excretory-secretory products.

Authors:  Jhang Ho Pak; Dong-Wook Kim; Ju Hyun Moon; Joo-Hyun Nam; Jong-Hyeok Kim; Jung Won Ju; Tong-Soo Kim; Sang-Beom Seo
Journal:  Parasitol Res       Date:  2008-11-28       Impact factor: 2.289

9.  Gene expression analysis in Interleukin-12-induced suppression of mouse mammary carcinoma.

Authors:  Xiaoyan Shi; Jianguo Liu; Zhaoying Xiang; Maki Mitsuhashi; Rita S Wu; Xiaojing Ma
Journal:  Int J Cancer       Date:  2004-07-01       Impact factor: 7.396

10.  The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores.

Authors:  Rafael A Irizarry; Christine Ladd-Acosta; Andrew P Feinberg; Bo Wen; Zhijin Wu; Carolina Montano; Patrick Onyango; Hengmi Cui; Kevin Gabo; Michael Rongione; Maree Webster; Hong Ji; James Potash; Sarven Sabunciyan
Journal:  Nat Genet       Date:  2009-01-18       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.